China news

BASF Opens PVP Facility in Shanghai

BASF announced on Sept. 27, 2016, the opening of a new plant for the manufacturing of polyvinylpyrrolidone (PVP) at the BASF site in Shanghai, China. The plant will produce PVP K30 powder, a polymer...
China policy

CFDA to strengthen regulation on overseas pharmaceutical products, the market pattern to change

In the eyes of most of the Chinese people engaging in the pharmaceutical industry, imported pharmaceutical products have been an area where the Chinese official regulation is weak, for which there...
biomedical industry

The Competitive Landscape of Global and Chinese Biomedical Industry

The global biomedical industry currently takes on the situation of concentrated development, and mainly distributes in the U.S., Europe, Japan, India, Singapore and China, etc., wherein, the U.S.,...

First Chinese-manufactured Biologic Dosed in EU Clinical Trial

This is the first time a biologic manufactured in China has been released for use in a clinical trial within countries in the EU. Read more
Chinese import and export of medicine in 2015

Foreign Trade of Chinese Medicine exceeded USD 100 Billion in 2015

Authorized to access data by China Customs, China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) published the import and export data report of medicines...
Dosage China

Promising Excipient & Dosage Market, Stable Social Demand for BPCs

Accounting for over 80% of drug's content, the quality of pharmaceutical excipients determine the risk of drug safety and play a key role in the quality of dosage. At CPhI China 2016, Excipients and...
BioPh China awaits you in Shanghai

BioPh China 2016 awaits you in June!

BioPh China 2016, hosted by UBM EMEA and China Chamber of Commerce of Medicines & Health Products Importers & Exporters and co-organized by UBM Sinoexpo, will be held in Hall E2 at Shanghai...

Biosimilars in global markets

Emerging markets may be key to long-term growth. Which ones? READ MORE TO FIND OUT.

China's Adagene raises $28 million

ingapore: Adagene, China based antibody discovery and development company, has raised USD28 million Series B financing led by GP Healthcare Capital along with New World TMT... READ MORE

China Drug Safety is improving, CFDA says

The China Food and Drug Administration (CFDA) said in a recent report that the country's food and drug safety industry has improved and that cases of illegal or bad drug fell in 2015 compared to 2014...